Congratulations to the finalists who have been recognized by their peers for the inspiring work they do each day – all collectively working to make a difference for those living with and affected by cancer.
February 22, 2021
March 26, 2021
August 30, 2021
Winners Announced &
Virtual Awards Ceremony
Cancer Community Awards
Cancer Community Awards
Redefining cancer care takes a community. From caregivers, healthcare professionals, advocacy groups, scientists, policymakers and so many others, the Cancer Community Awards (or C2 Awards) celebrate the unsung heroes of cancer care, whose relentless drive to affect positive change has given new hope to those affected by this devastating disease.
Consider nominating a caregiver who supports patients in times of extraordinary need, an organization that fights to overcome cancer disparities for medically underserved patients, an advocate who educates and empowers patients, or a community health administrator who brings the latest treatment paradigms to distant areas. Collectively, these entities make an enormous difference but often fall outside the bounds of traditional oncology recognition programs.
Our awards recognize individuals and organizations across five unique categories. Nominees should have a compelling story about how their work is positively impacting cancer care. Nominees must be based in the United States.
Finalists and winners in the Catalyst for Change, Catalyst for Equity, Catalyst for Care and Catalyst for Precision Medicine categories were selected by an esteemed panel of judges from across the cancer community.
Scientific advancements in cancer care and treatment can save lives, but often ensuring that these advancements reach the community-level or more remote areas can be a challenge due to economic barriers, or a lack of education and awareness. Nominees for the C2 Catalyst for Change Award are working to change that.
Nominees for this award have worked to bring high-quality cancer care to patients at the local community-, neighborhood-, or hospital-level that results in better cancer care for more people.
Nominees for this award drive change that results in better cancer care for more people. Maybe a Nominee found a way to get more people screened for cancer at an earlier stage or figured out a creative approach for their community to access new treatments or facilities. Or perhaps the Nominee created a science-based communication, initiative or event that improved access to cancer care and treatment. The C2 Catalyst for Change Award celebrates those who significantly improve access to cancer care in their community.
- A nominee needs to significantly improve local access to high-quality cancer care. Examples might include:
- Creating more space at a facility that lacked it, facilitating the treatment of more patients.
- Developing an educational cancer-prevention program in a region with a lack of knowledge.
- Improving a community’s ability to serve cancer patients through advocacy, government relations, or media attention.
- A Nominee should be able to demonstrate measurable impact, whether as people reached, populations served, procedures increased, screens undertaken, etcetera.
- Ideally, a Nominee’s process/methodology/approach could be applied in other communities to further expand access to patients in other communities.
Nominees for this new award have worked to overcome longstanding racial and ethnic disparities in cancer care so that all patients have equitable access to quality cancer care, including preventive screens and the latest treatments.
Nominees for the C2 Catalyst for Equity Award break down barriers to care, ensuring historically underserved, and underrepresented, patient populations have access to life-saving cancer screenings and treatments.
Perhaps a Nominee worked with community leaders or organizations to address racial bias in healthcare, launched patient-education programs to elevate the voice of patients from diverse backgrounds, improved health literacy in a specific population, or supported the growth and development of healthcare professionals of tomorrow. The C2 Catalyst for Equity Award celebrates those who significantly create greater equity in cancer care.
- A Nominee needs to significantly address cancer disparities for historically underserved patient groups who often experience poorer outcomes, including later diagnosis and higher incidence of mortality. According to the National Cancer Institute, these communities may include Black people, Hispanics and Latinos, Asians and Pacific Islanders, as well as Native Americans and Alaska Natives. Examples might include:
- Bringing treatment and quality cancer care for patients from an underserved racial or ethnic group.
- Developing an education, outreach, or clinical program purpose built to equalize access to quality cancer care.
- Finding ways to make cancer care more equitable through innovative economics and technologies.
- A Nominee should be able to demonstrate measurable impact, whether as people reached, populations served, procedures increased, screens undertaken, partners involved.
- Ideally, a Nominee’s process/methodology/approach could be applied in other communities to further expand access to similarly underserved patient populations.
Nominees for this award improve the cancer-care experience for patients and their loved ones.
How a patient feels during a treatment and what happens to a patient outside the clinic matters just as much as the treatment itself. Nominees for the C2 Catalyst for Care Award work to improve the patient experience.
A Nominee may have developed a system where providers go to patients, helped to make hospitals look like homes, or created a transportation service to provide free rides to medical appointments. A Nominee may help patients or their families manage challenges beyond medical care, such as finances or quality-of-life issues. This award is all about making a patient’s experience as easy as possible during an extraordinarily difficult time.
- A Nominee needs to significantly enhance the experience of cancer care for patients at some stage in their cancer treatment, from diagnosis and beyond. Examples might include:
- Developing improved hospital facilities or quality-of-care programs, such as new wards, food menus or transportation services.
- Advocating for improved quality-of-life services.
- Creating easy-to-use digital adherence tools.
- Improving the experience of patient families, helping them navigate a very difficult time.
- A winner should be able to demonstrate measurable impact, whether as patients reached, programs started, meals prepared, rides given, etcetera.
- Ideally, the tools or techniques required to implement the winner’s advance should be something that could apply to cancer-care across the country.
A Nominee for this award significantly advances precision medicine in oncology to bring new, more personalized tests or treatments to patients.
Many of the most promising advances in cancer care come from the area of precision oncology, which uses specific characteristics of a patient’s cancer to inform doctors what the best treatment may be for that individual. A Nominee of the C2 Catalyst for Precision Medicine Award is expanding the boundaries for how to personalize care for each patient, bringing new, more individualized tests and treatments to patients and improving health outcomes in the process.
A Nominee might have pioneered new research to help oncologists understand the genetics of a patient’s cancer differently and thereby provide better treatment options. Or a Nominee may have created new protocols to identify which specific patients may benefit from a specific treatment protocol. This award celebrates those who enhance the ability to provide the right treatment for the right patient at the right time.
- A Nominee needs to significantly improve personalized treatments for cancer patients, giving them new options. Examples include:
- Developing a new kind of precision-oncology method that leads to measurable improvements in health outcomes.
- Developing tools to help identify patients who may benefit from a new precision-oncology approach.
- Leading research that identifies new, more personalized options for cancer treatment.
- Spearheading a new policy to enhance testing or screening for a specific cancer mutation.
- A winner should be able to demonstrate measurable impact, such as patients treated, programs started, etcetera.
- Ideally, the tools or techniques required to implement the winner’s advance should be something that could apply across the country.
Cancer does not have any fixed rules, nor does the President’s Award, save one: The winner must make a tangible and inspiring difference in the lives of patients or their loved ones. A Nominee may have started a 5K race to raise enough money to pay a certain patient’s treatment. A Nominee may have built a cancer survivor support group or online forum. A Nominee might even have changed a loved one’s life by becoming an advocate or caregiver or a volunteer hospice worker. The President’s Award is selected by an AstraZeneca executive for making a meaningful impact on the lives of cancer patients.
- The winner’s contributions benefited the cancer community in an inspirational way that lies outside of the criteria for the other C2 Awards.
- This winner should show an unexpected way to contribute to the cancer community and demonstrate how they have improved the life of even one cancer patient.
We’re excited to spotlight the four winners of the Cancer Community Awards 2020 for the inspiring work they have done to help and support cancer patients and their loved ones. Hear their stories:
The program is a partnership between AstraZeneca and Scientific American Custom Media and nominees will be selected by a broad group of experts drawn from our community.
Scientific American has been bringing its global audience unique insights into science, technology and medicine for more than 175 years. The C2 Awards are a partnership with Scientific American Custom Media, working with a group patient advocates, caregivers, healthcare providers, leaders in industry and members of government agencies to select Nominees.